109 related articles for article (PubMed ID: 20021426)
1. Targeting cancer cells by an oxidant-based therapy.
Verrax J; Taper H; Buc Calderon P
Curr Mol Pharmacol; 2008 Jan; 1(1):80-92. PubMed ID: 20021426
[TBL] [Abstract][Full Text] [Related]
2. Altered deoxyribonuclease activity in cancer cells and its role in non toxic adjuvant cancer therapy with mixed vitamins C and K3.
Taper HS
Anticancer Res; 2008; 28(5A):2727-32. PubMed ID: 19035302
[TBL] [Abstract][Full Text] [Related]
3. Role of glycolysis inhibition and poly(ADP-ribose) polymerase activation in necrotic-like cell death caused by ascorbate/menadione-induced oxidative stress in K562 human chronic myelogenous leukemic cells.
Verrax J; Vanbever S; Stockis J; Taper H; Calderon PB
Int J Cancer; 2007 Mar; 120(6):1192-7. PubMed ID: 17163414
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress therapy for solid tumors - a proposal.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2010 Jun; 74(6):1052-4. PubMed ID: 20089364
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxic action of vitamin C and vitamin K3.
Zhang W; Negoro T; Satoh K; Jiang Y; Hashimoto K; Kikuchi H; Nishikawa H; Miyata T; Yamamoto Y; Nakano K; Yasumoto E; Nakayachi T; Mineno K; Satoh T; Sakagami H
Anticancer Res; 2001; 21(5):3439-44. PubMed ID: 11848506
[TBL] [Abstract][Full Text] [Related]
6. Autoschizis: another cell death for cancer cells induced by oxidative stress.
Gilloteaux J; Jamison JM; Arnold D; Summers JL
Ital J Anat Embryol; 2001; 106(2 Suppl 1):79-92. PubMed ID: 11730000
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice.
Verrax J; Stockis J; Tison A; Taper HS; Calderon PB
Biochem Pharmacol; 2006 Sep; 72(6):671-80. PubMed ID: 16828058
[TBL] [Abstract][Full Text] [Related]
8. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment.
Calderon PB; Cadrobbi J; Marques C; Hong-Ngoc N; Jamison JM; Gilloteaux J; Summers JL; Taper HS
Curr Med Chem; 2002 Dec; 9(24):2271-85. PubMed ID: 12470246
[TBL] [Abstract][Full Text] [Related]
9. Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM; Ullah MF; Shamim U; Bhatt SH; Azmi AS
Chemotherapy; 2010; 56(4):280-4. PubMed ID: 20714144
[TBL] [Abstract][Full Text] [Related]
10. Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells.
Briedé JJ; van Delft JM; de Kok TM; van Herwijnen MH; Maas LM; Gottschalk RW; Kleinjans JC
Toxicol Sci; 2010 Apr; 114(2):193-203. PubMed ID: 20044591
[TBL] [Abstract][Full Text] [Related]
11. The controversial place of vitamin C in cancer treatment.
Verrax J; Calderon PB
Biochem Pharmacol; 2008 Dec; 76(12):1644-52. PubMed ID: 18938145
[TBL] [Abstract][Full Text] [Related]
12. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract][Full Text] [Related]
13. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
Ogawa M; Nakai S; Deguchi A; Nonomura T; Masaki T; Uchida N; Yoshiji H; Kuriyama S
Int J Oncol; 2007 Aug; 31(2):323-31. PubMed ID: 17611688
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death.
Beck R; Verrax J; Gonze T; Zappone M; Pedrosa RC; Taper H; Feron O; Calderon PB
Biochem Pharmacol; 2009 Feb; 77(3):375-83. PubMed ID: 19014912
[TBL] [Abstract][Full Text] [Related]
15. Ascorbate combination therapy: new tool in the anticancer toolbox?
McConnell MJ; Herst PM
Sci Transl Med; 2014 Feb; 6(222):222fs6. PubMed ID: 24500402
[TBL] [Abstract][Full Text] [Related]
16. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
17. [Role of vitamins E and C in the development of the malignant process].
Morozkina TS
Eksp Onkol; 1986; 8(3):3-10. PubMed ID: 3522196
[TBL] [Abstract][Full Text] [Related]
18. A two-phase strategy for treatment of oxidant-dependent cancers.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2007; 69(3):489-96. PubMed ID: 17502128
[TBL] [Abstract][Full Text] [Related]
19. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action.
De Loecker W; Janssens J; Bonte J; Taper HS
Anticancer Res; 1993; 13(1):103-6. PubMed ID: 8476199
[TBL] [Abstract][Full Text] [Related]
20. Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity -- a systematic review.
Putchala MC; Ramani P; Sherlin HJ; Premkumar P; Natesan A
Arch Oral Biol; 2013 Jun; 58(6):563-74. PubMed ID: 23477602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
